Multiple localization of endogenous MARK4L protein in human glioma

Ivana Magnani, Chiara Novielli, Melissa Bellini, Gaia Roversi, Lorenzo Bello, Lidia Larizza

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: We have previously shown that the sustained expression of MARK4L transcripts in glioma and neural progenitors (NHNPs) declines after exposure to antisense MARK4L oligonucleotides in glioblastoma cell lines. Array-CGH confirmed the genomic duplication of MARK4L identified by FISH in a glioblastoma cell line. This background together with literature data on the exogenous association of MARK4 with interphase centrosome prompted us to investigate the sub-cellular localization of the endogenous MARK4L protein aiming at achieving insights on its possible role in the pathomechanisms of glioma. Methods: Immunodetection was carried out to validate the specificity of MARK4L antibody in gliomas and NHNPs. Mass spectrometry was applied for MARK4L protein identification in a representative glioblastoma cell line. Combined biochemical fractionation and immunodetection analyses were performed to confirm the sub-cellular localization of MARK4L achieved by immunofluorescence in glioma cell lines. Results: By assigning MARK4L protein within the band immunoprecipitated by the specific antibody we validated our antiMARK4L antibody. We demonstrated that the endogenous MARK4L: (i) colocalizes with centrosomes at all mitotic stages and resides in centrosome-enriched fractions; (ii) associates with the nucleolus and the midbody and respective fractions, and (iii) co-stains the aberrant centrosome configurations observed in glioma cell lines. Conclusion: The overall data merge on the multiplex entry of MARK4L into the cell cycle and link it to the aberrant centrosomes in glioma cell lines suggesting a possible role of this kinase in the abnormal mitotic processes of human glioma.

Original languageEnglish
Pages (from-to)357-370
Number of pages14
JournalCellular Oncology
Volume31
Issue number5
DOIs
Publication statusPublished - 2009

Fingerprint

Glioma
Centrosome
Cell Line
Glioblastoma
Proteins
Antibody Specificity
Antibodies
Antisense Oligonucleotides
Interphase
human MARK4 protein
Fluorescent Antibody Technique
Mass Spectrometry
Cell Cycle
Coloring Agents
Phosphotransferases

Keywords

  • Centrosome abnormalities
  • Glioma
  • Immunodetection
  • MARK4L
  • Multiple subcellular localization

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine

Cite this

Multiple localization of endogenous MARK4L protein in human glioma. / Magnani, Ivana; Novielli, Chiara; Bellini, Melissa; Roversi, Gaia; Bello, Lorenzo; Larizza, Lidia.

In: Cellular Oncology, Vol. 31, No. 5, 2009, p. 357-370.

Research output: Contribution to journalArticle

Magnani, Ivana ; Novielli, Chiara ; Bellini, Melissa ; Roversi, Gaia ; Bello, Lorenzo ; Larizza, Lidia. / Multiple localization of endogenous MARK4L protein in human glioma. In: Cellular Oncology. 2009 ; Vol. 31, No. 5. pp. 357-370.
@article{77f0a95d8763498bab99f70c765f8eac,
title = "Multiple localization of endogenous MARK4L protein in human glioma",
abstract = "Background: We have previously shown that the sustained expression of MARK4L transcripts in glioma and neural progenitors (NHNPs) declines after exposure to antisense MARK4L oligonucleotides in glioblastoma cell lines. Array-CGH confirmed the genomic duplication of MARK4L identified by FISH in a glioblastoma cell line. This background together with literature data on the exogenous association of MARK4 with interphase centrosome prompted us to investigate the sub-cellular localization of the endogenous MARK4L protein aiming at achieving insights on its possible role in the pathomechanisms of glioma. Methods: Immunodetection was carried out to validate the specificity of MARK4L antibody in gliomas and NHNPs. Mass spectrometry was applied for MARK4L protein identification in a representative glioblastoma cell line. Combined biochemical fractionation and immunodetection analyses were performed to confirm the sub-cellular localization of MARK4L achieved by immunofluorescence in glioma cell lines. Results: By assigning MARK4L protein within the band immunoprecipitated by the specific antibody we validated our antiMARK4L antibody. We demonstrated that the endogenous MARK4L: (i) colocalizes with centrosomes at all mitotic stages and resides in centrosome-enriched fractions; (ii) associates with the nucleolus and the midbody and respective fractions, and (iii) co-stains the aberrant centrosome configurations observed in glioma cell lines. Conclusion: The overall data merge on the multiplex entry of MARK4L into the cell cycle and link it to the aberrant centrosomes in glioma cell lines suggesting a possible role of this kinase in the abnormal mitotic processes of human glioma.",
keywords = "Centrosome abnormalities, Glioma, Immunodetection, MARK4L, Multiple subcellular localization",
author = "Ivana Magnani and Chiara Novielli and Melissa Bellini and Gaia Roversi and Lorenzo Bello and Lidia Larizza",
year = "2009",
doi = "10.3233/CLO-2009-0481",
language = "English",
volume = "31",
pages = "357--370",
journal = "Cellular oncology (Dordrecht)",
issn = "2211-3428",
publisher = "IOS Press",
number = "5",

}

TY - JOUR

T1 - Multiple localization of endogenous MARK4L protein in human glioma

AU - Magnani, Ivana

AU - Novielli, Chiara

AU - Bellini, Melissa

AU - Roversi, Gaia

AU - Bello, Lorenzo

AU - Larizza, Lidia

PY - 2009

Y1 - 2009

N2 - Background: We have previously shown that the sustained expression of MARK4L transcripts in glioma and neural progenitors (NHNPs) declines after exposure to antisense MARK4L oligonucleotides in glioblastoma cell lines. Array-CGH confirmed the genomic duplication of MARK4L identified by FISH in a glioblastoma cell line. This background together with literature data on the exogenous association of MARK4 with interphase centrosome prompted us to investigate the sub-cellular localization of the endogenous MARK4L protein aiming at achieving insights on its possible role in the pathomechanisms of glioma. Methods: Immunodetection was carried out to validate the specificity of MARK4L antibody in gliomas and NHNPs. Mass spectrometry was applied for MARK4L protein identification in a representative glioblastoma cell line. Combined biochemical fractionation and immunodetection analyses were performed to confirm the sub-cellular localization of MARK4L achieved by immunofluorescence in glioma cell lines. Results: By assigning MARK4L protein within the band immunoprecipitated by the specific antibody we validated our antiMARK4L antibody. We demonstrated that the endogenous MARK4L: (i) colocalizes with centrosomes at all mitotic stages and resides in centrosome-enriched fractions; (ii) associates with the nucleolus and the midbody and respective fractions, and (iii) co-stains the aberrant centrosome configurations observed in glioma cell lines. Conclusion: The overall data merge on the multiplex entry of MARK4L into the cell cycle and link it to the aberrant centrosomes in glioma cell lines suggesting a possible role of this kinase in the abnormal mitotic processes of human glioma.

AB - Background: We have previously shown that the sustained expression of MARK4L transcripts in glioma and neural progenitors (NHNPs) declines after exposure to antisense MARK4L oligonucleotides in glioblastoma cell lines. Array-CGH confirmed the genomic duplication of MARK4L identified by FISH in a glioblastoma cell line. This background together with literature data on the exogenous association of MARK4 with interphase centrosome prompted us to investigate the sub-cellular localization of the endogenous MARK4L protein aiming at achieving insights on its possible role in the pathomechanisms of glioma. Methods: Immunodetection was carried out to validate the specificity of MARK4L antibody in gliomas and NHNPs. Mass spectrometry was applied for MARK4L protein identification in a representative glioblastoma cell line. Combined biochemical fractionation and immunodetection analyses were performed to confirm the sub-cellular localization of MARK4L achieved by immunofluorescence in glioma cell lines. Results: By assigning MARK4L protein within the band immunoprecipitated by the specific antibody we validated our antiMARK4L antibody. We demonstrated that the endogenous MARK4L: (i) colocalizes with centrosomes at all mitotic stages and resides in centrosome-enriched fractions; (ii) associates with the nucleolus and the midbody and respective fractions, and (iii) co-stains the aberrant centrosome configurations observed in glioma cell lines. Conclusion: The overall data merge on the multiplex entry of MARK4L into the cell cycle and link it to the aberrant centrosomes in glioma cell lines suggesting a possible role of this kinase in the abnormal mitotic processes of human glioma.

KW - Centrosome abnormalities

KW - Glioma

KW - Immunodetection

KW - MARK4L

KW - Multiple subcellular localization

UR - http://www.scopus.com/inward/record.url?scp=70149116823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70149116823&partnerID=8YFLogxK

U2 - 10.3233/CLO-2009-0481

DO - 10.3233/CLO-2009-0481

M3 - Article

VL - 31

SP - 357

EP - 370

JO - Cellular oncology (Dordrecht)

JF - Cellular oncology (Dordrecht)

SN - 2211-3428

IS - 5

ER -